Carmot Therapeutics, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Carmot Therapeutics, based in Berkeley, California, is a clinical-stage biotechnology company focused on developing therapies for obesity and diabetes. The company pursues its programs with a proprietary drug-discovery platform designed to identify novel targets in incretin receptor signaling and to build a broad pipeline of therapeutics. Its clinical program includes three candidates: CT-388, CT-868, and CT-996. In early 2024, Carmot Therapeutics became part of the Roche Group through acquisition. The organization operates within the biotechnology research space and aims to advance therapies that improve weight management and glycemic control for people with obesity and diabetes. As a small, specialized team, the company continues to develop its metabolic-disease portfolio under Roche's corporate umbrella.